Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· January 30, 2026
Lilly selects Pennsylvania as home for its newest injectable medicine and device manufacturing facility
View original at finance.yahoo.comLilly selects Pennsylvania as home for its newest injectable medicine and device manufacturing facility The $3.5 billion Lehigh Valley site will develop Lilly's next-generation weight-loss medicines, including retatrutide Company plans to create more than 2,800 manufacturing and construction jobs at Lilly's 10th U.S…
What we drew from this source
The claims Via News extracted from this document. We point to the source; we don't replace it.
Having modern, robust pharmaceutical manufacturing capabilities here in the United States is essential for both our national security and domestic economy
80% confidenceThis multi-billion dollar investment in the Lehigh Valley is a powerful testament to Pennsylvania's leadership in life sciences and advanced manufacturing
80% confidence
Cited in these Via News reports
- AI Governance Body AAIF Adds 97 Members as Visual Reasoning Gaps Challenge Global Deployment →
- AI Solves Complex Math Problems in Hours on Single Machines, Reshaping Global Research Access →
- OpenAI Chief Scientist Predicts Autonomous AI Research Labs Operating Without Human Oversight →
- OpenAI Scientist Envisions Autonomous Research Labs Operating in Data Centers for Months →
- OpenAI Scientist: Autonomous AI Research Labs Arriving Within Months →
- OpenAI Targets Autonomous AI Systems That Work Days Without Human Oversight →
- OpenAI Targets Fully Autonomous AI Research Labs That Run Without Human Scientists →